Skip to main content

Table 2 Comparison of test data among three groups

From: Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction

 

NC(n = 45)

DM(n = 45)

DMED(n = 45)

P

DBIL(umol/L)

4.14 ± 0.21

3.85 ± 0.22

4.36 ± 0.22

0.249

IBIL(umol/L)

7.22 ± 0.45

7.16 ± 0.53

8.45 ± 0.46

0.769

ALT(U/L)

20.3(12.4,28.25)

17.9(12.8,24.8)

18.0(12.85,23.65)

0.769

AST(U/L)

20.5(17.0,28.0)

20.7(17.65,25.30)

20.0(15.85,23.25)

0.331

UREA(mmol/L)

267.69 ± 9.35

275.09 ± 0.11.33

297.04 ± 0.13.27

0.172

CREA(umol/L)

64.24 ± 1.94

62.14 ± 1.77

63.35 ± 1.84

0.695

TC(mmol/L)

4.64(4.01,5.56)

5.10(4.34,5.67)

4.85(4.22,5.60)

0.501

TG(mmol/L)

1.18(0.78,1.71)

1.32(0.97,1.81)

1.30(1.05,2.03)

0.217

HDL(mmol/L)

1.34(1.18,1.67)

1.41(1.19,1.58)

1.34(1.12,1.51)

0.437

LDL(mmol/L)

3.13 ± 0.13

3.30 ± 0.11

3.15 ± 0.13

0.543

TT(nmol/l)

9.74(8.95,10.42)

9.74(8.93,9.86)

9.69(8.78,9.85)

0.308

HBA1C (%)

4.50(4.25,4.80)

8.20(7.85,9.25)a

8.50(8.25,10.60)a

0.000

BF(%)

32.20(28.65,37.30)

36.50(30.70,38.40)a

36.90(32.35,39.20)a

0.009

VAT (cm2)

100.00(76.4,111.50)

113.00(104.00,123.50)a

124.00(104.50,136.50)a

p < 0.001

Fatty liver (n,%)

5(11.1%)

17(37.78)a

19(42.2)2%a

0.002

  1. Abbreviations: DM: Diabetes Mellitus; BMI: Body Mass Index; WC: Waist circumference; WHR: Waist-to-Hip Ratio; SBP: Systolic Blood Pressure; DBP: Diastolic blood pressure; DPP-IVi: Dipeptidyl peptidase 4 inhibitors; GLP-1RA: Glucagon-like peptide 1 receptor Agonist; SGLT2i: Sodium-dependent glucose transporters 2 inhibitors; TZDs: Thiazolidinediones; ACEI/ARB: Angiotension converting enzyme inhibitors/Angiotensin Receptor Blocker; CCB: Calcium channel blockers; DBIL: Direct Bilirubin; IBIL: Indirect Bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CREA: Creatinine; TC: Cholesterol, TG: Triglyceride, HDL: High Density Lipoprotein; TT: Total testosterone; HBA1C: Hemoglobin A1c; BF%:percentage of body fat. VAT: Visceral adipose tissue;